TrialRMD open2021

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial.

Laurette van Boheemen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.